Please enter valid quantity
Please log in to add favorites.
NULL OR EMPTY CART
With PerkinElmer’s IVISbrite Coelenterazine h Bioluminescent Substrate in RediJect Solution, you can ensure reproducible results by minimizing variability in formulation, minimizing freeze/thaw and controlling batch to batch variation. IVISbrite Coelenterazine h bioluminescent substrate has been pre-formulated to fit common workflow patterns and optimize results for all your experiments with Renilla luciferase. The ready to use substrate formulation allows you to concentrate on animal handling and biology.
|Product Brand Name||IVISbrite|
|Quantity in a Package Amount||10.0 Units|
|Shipping Condition||Blue Ice|
|Unit Size||1 Kit (10 Vials)|
Researchers trust our in vivo imaging solutions to give them reliable, calibrated data that reveals pathway characterization and therapeutic efficacies for a broad range of indications. Our reagents, instruments, and applications support have helped hundreds of research projects over the years. And our hard-earned expertise makes us a trusted provider of pre-clinical imaging solutions— with more than 9,000 peer reviewed articles as proof.
RediJect Coelenterazine h is a bioluminescence substrate in a ready-to-use format developed by the in vivo imaging leaders to fit your laboratory workflow. With PerkinElmer’s RediJect Coelenterazine you can ensure reproducible results by minimizing variability in formulation, minimizing freeze/thaw and controlling batch to batch variation. RediJect Coelenterazine has been formulated to fit common workflow patterns and optimize results for all your experiments with Renilla luciferase. This ready-to-use substrate formulation allows you to concentrate on animal handling and biology.
The goal of in vivo fluorescence molecular imaging is to enable non-invasive visualization and quantification of cellular and biological functioning to better understand and characterize disease processes and treatment effects earlier within the context of a biological system.
This selector guide for IVISense™ fluorescent probes is a powerful tool to help advance your oncology research. By matching probe properties to specific biology and biomarker characteristics, you can better understand how imaging and quantification of early biological changes associated with disease development, therapeutic efficacy, and drug-induced tissue changes can be realized.
The primary goal of preclinical imaging is to improve the odds of clinical success and reduce drug discovery and development time and costs. Advances in non-invasive in vivo imaging techniques have raised the use of animal models in drug discovery and development to a new level by enabling quick and efficient drug screening and evaluation. Read this White Paper to learn how preclinical in vivo imaging helps to ensure that smart choices are made by providing Go/No-Go decisions and de-risking drug candidates early on, significantly reducing time to the clinic and lowering costs all while maximizing biological understanding.